Improving meningitis diagnosis and treatment in rural Uganda
Etiology and Outcomes of Meningitis in Rural, Northern Uganda
This study is working to improve how meningitis is diagnosed and treated in rural northern Uganda, helping people who show symptoms by providing quick tests for HIV and cryptococcal meningitis, with the goal of saving lives and reducing disabilities in the community.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10693970 on NIH RePORTER |
What this research studies
This research aims to enhance the diagnosis and treatment of meningitis in rural northern Uganda, an area significantly impacted by this disease. The project involves a collaborative effort to implement a comprehensive diagnosis and treatment program for cryptococcal meningitis, which includes rapid HIV and cryptococcal antigen testing for patients showing symptoms of meningitis. By improving healthcare infrastructure and treatment protocols, the research seeks to reduce mortality and disability associated with meningitis in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in rural northern Uganda who exhibit symptoms of meningitis, particularly those who are HIV-positive.
Not a fit: Patients outside of rural northern Uganda or those without symptoms of meningitis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnosis and treatment of meningitis, ultimately saving lives and improving the quality of life for affected individuals.
How similar studies have performed: Previous initiatives aimed at improving meningitis diagnosis and treatment in similar settings have shown promising results, indicating that this approach has potential for success.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Bohjanen, Paul R — University of Rochester
- Study coordinator: Bohjanen, Paul R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.